Prostanoid receptors and phosphatidylinositol 3-kinase: A pathway to cancer?

Hiromichi Fujino, John W Regan

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

The significance of receptor heterogeneity has, in many cases, been unclear, particularly in the case of closely related receptor subtypes that are activated by the same endogenous ligands and appear to signal through the same second messenger pathways. In this article, recent studies of the EP and FP prostanoid receptors are reviewed, showing that receptor subtypes previously thought to activate the same signaling pathways, in fact, differ through novel interactions with phosphatidylinositol 3-kinase and activation of nuclear signaling pathways. These findings might be applicable to other families of G-protein-coupled receptors and have implications in cancer and other diseases.

Original languageEnglish (US)
Pages (from-to)335-340
Number of pages6
JournalTrends in Pharmacological Sciences
Volume24
Issue number7
DOIs
StatePublished - Jul 1 2003

Fingerprint

Phosphatidylinositol 3-Kinase
Second Messenger Systems
G-Protein-Coupled Receptors
Prostaglandins
Ligands
Neoplasms
Chemical activation
prostaglandin F2alpha receptor

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Prostanoid receptors and phosphatidylinositol 3-kinase : A pathway to cancer? / Fujino, Hiromichi; Regan, John W.

In: Trends in Pharmacological Sciences, Vol. 24, No. 7, 01.07.2003, p. 335-340.

Research output: Contribution to journalArticle

@article{ae54a7defb754ef8b78bb379efb9b4c0,
title = "Prostanoid receptors and phosphatidylinositol 3-kinase: A pathway to cancer?",
abstract = "The significance of receptor heterogeneity has, in many cases, been unclear, particularly in the case of closely related receptor subtypes that are activated by the same endogenous ligands and appear to signal through the same second messenger pathways. In this article, recent studies of the EP and FP prostanoid receptors are reviewed, showing that receptor subtypes previously thought to activate the same signaling pathways, in fact, differ through novel interactions with phosphatidylinositol 3-kinase and activation of nuclear signaling pathways. These findings might be applicable to other families of G-protein-coupled receptors and have implications in cancer and other diseases.",
author = "Hiromichi Fujino and Regan, {John W}",
year = "2003",
month = "7",
day = "1",
doi = "10.1016/S0165-6147(03)00162-7",
language = "English (US)",
volume = "24",
pages = "335--340",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Prostanoid receptors and phosphatidylinositol 3-kinase

T2 - A pathway to cancer?

AU - Fujino, Hiromichi

AU - Regan, John W

PY - 2003/7/1

Y1 - 2003/7/1

N2 - The significance of receptor heterogeneity has, in many cases, been unclear, particularly in the case of closely related receptor subtypes that are activated by the same endogenous ligands and appear to signal through the same second messenger pathways. In this article, recent studies of the EP and FP prostanoid receptors are reviewed, showing that receptor subtypes previously thought to activate the same signaling pathways, in fact, differ through novel interactions with phosphatidylinositol 3-kinase and activation of nuclear signaling pathways. These findings might be applicable to other families of G-protein-coupled receptors and have implications in cancer and other diseases.

AB - The significance of receptor heterogeneity has, in many cases, been unclear, particularly in the case of closely related receptor subtypes that are activated by the same endogenous ligands and appear to signal through the same second messenger pathways. In this article, recent studies of the EP and FP prostanoid receptors are reviewed, showing that receptor subtypes previously thought to activate the same signaling pathways, in fact, differ through novel interactions with phosphatidylinositol 3-kinase and activation of nuclear signaling pathways. These findings might be applicable to other families of G-protein-coupled receptors and have implications in cancer and other diseases.

UR - http://www.scopus.com/inward/record.url?scp=0042734625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042734625&partnerID=8YFLogxK

U2 - 10.1016/S0165-6147(03)00162-7

DO - 10.1016/S0165-6147(03)00162-7

M3 - Article

C2 - 12871665

AN - SCOPUS:0042734625

VL - 24

SP - 335

EP - 340

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 7

ER -